Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SIX5 |
| Upstream (Parents) |
|---|
| (<<) NKX2-1 → SIX5 |
| (<<) HOXD3 → SIX5 |
| (<<) TSC22D2 → SIX5 |
| (<<) FOXO3 → SIX5 |
| (<<) TP53 → SIX5 |
| (<<) MTA2 → SIX5 |
| (<<) HSF1 → SIX5 |
| (<<) TSC22D4 → SIX5 |
| (<<) STAT1 → SIX5 |
| (<<) ETV5 → SIX5 |
| (<<) BCL3 → SIX5 |
| (<<) BUD31 → SIX5 |
| (<<) RBCK1 → SIX5 |
| Downstream (Children) |
|---|
| SIX5 → IRF4 (>>) |
| SIX5 → POU6F2 (>>) |
| SIX5 → BRD8 (>>) |
| SIX5 → ZNF154 (>>) |
| SIX5 → TBX4 (>>) |
